Clinical Trials Logo

Clinical Trial Summary

Management of postoperative urinary retention often requires the use of indwelling catheters. In a previous study, the investigators determined that patient removal of catheters at home is non-inferior to standard office removal on postoperative day three or four (POD3-4). The purpose of this study is to determine whether patient removal of catheters at home on postoperative day one (POD1) is noninferior to removal on POD 3-4.


Clinical Trial Description

Randomized, controlled, non-inferiority trial to compare the risk of urinary retention between patient urinary catheter removal on POD1 versus POD3-4 after urogynecologic surgery. Aim One: Is the risk of urinary retention non-inferior with patient removal of transurethral catheters on POD1 versus POD3-4 after urogynecologic surgery? Aim Two: Does healthcare resource utilization (nursing calls, patient messages, and office visits) differ between patient removal of transurethral catheters on POD1 versus POD3-4? Aim Three: Does the patient experience differ between patient removal of transurethral catheters on POD1 versus POD3-4? Aim Four: Does the incidence of postoperative UTI differ between patient removal of transurethral catheters on POD1 versus POD3-4? Aim Five: Does the risk of delayed or recurrent postoperative urinary retention differ between patient removal of transurethral catheters on POD1 versus POD3-4? Screening: Preoperative clinics at UNC Rex Urogynecology will be screened for all women who are undergoing a prolapse or anti-incontinence procedure. Study Treatment/Intervention Postoperatively if patients fail their voiding trial in the post-anesthesia care unit (PACU) and are willing to perform home catheter removal after instruction Patients will be randomized to a catheter management arm: self-catheter removal on POD1 or POD3-4 POD 1 - Patients in the intervention arm will be reminded to remove their catheters They will be instructed to remove their urinary catheter at 0700 and to call the clinic office by noon if they have not voided If they are unable to void or have any other concerning symptoms, they will be scheduled for a same day nurse visit Patients who are unable to void will then be taught clean intermittent self-catheterization, per usual management of postoperative voiding dysfunction POD 3 (or by POD 4 for Thursday cases) - Patients in the control arm will be reminded to remove their catheters * Patients undergoing surgery on Thursday will perform catheter removal on Monday. This is what was done in previous studies in order to prevent resource over-utilization on weekends. Patients undergoing surgery on Wednesday (typically only rare add-on cases) will be excluded. They will be instructed to remove their urinary catheter at 0700 and to call the clinic office by noon if they have not voided If they are unable to void or have any other concerning symptoms, they will be scheduled for a same day nurse visit Patients who are unable to void will then be taught clean intermittent self-catheterization, per usual management of postoperative voiding dysfunction Week 2 Phone Call Patients will be called by study personnel to check in on any voiding symptoms or issues and complete phone survey regarding the following categories: Pain, Ease of use, Satisfaction, Likelihood to use again. Week 6 Visit Patients will have a standard office visit around 6 weeks postoperatively. At this visit, a post-void residual assessment will be performed. Follow-up through postoperative visit after surgery Postoperative complications, such as urinary tract infection (UTI) or delayed urinary retention will be monitored from the chart Patients will be randomized on the day of surgery. Each subject's participation will last from the day of surgery to the day of catheter removal (on POD 1-4). They will also be called two weeks postoperatively for a check-in and survey over the phone. Postoperative complications will be monitored until their postoperative visit at 6-8 weeks after surgery. The recruitment and data collection period is expected to last one year. The entire study including data collection, analysis and publication will take up to 3 years. - ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06344884
Study type Interventional
Source University of North Carolina, Chapel Hill
Contact Lauren Tholemeier, MD
Phone 984-974-0496
Email lthol@email.unc.edu
Status Not yet recruiting
Phase N/A
Start date May 2024
Completion date July 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05794503 - Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex Early Phase 1
Active, not recruiting NCT04010656 - Optimization of Spontaneous Postoperative Trial of Void Among Women N/A
Recruiting NCT04597372 - Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery Phase 2
Recruiting NCT04707001 - Urinary Retention After Arthroplasty N/A
Recruiting NCT06241703 - Effect of ICCAUT Strategy on Postoperative Urinary Dysfunction After Radical Rectal Cancer Surgery N/A
Terminated NCT05353400 - At Home Early vs. Delayed Catheter Removal Following Failed Postoperative Voiding Trial: a Randomized Trial N/A
Completed NCT03818321 - Urinary Track Infection Prevention After Urogynecological Surgery Phase 2
Not yet recruiting NCT06262048 - Prevention of Post Operative Urinary Retention After Thoracic Surgery Trial Phase 2
Recruiting NCT05020613 - Early and Late Removal of the Urinary Catheter After Rectum Resection N/A
Completed NCT03071211 - Catheter Management After Pelvic Reconstructive Surgery N/A
Recruiting NCT05249192 - Immediate Versus Early (24-hours) Urinary Catheter Removal After Elective Minimally Invasive Colonic Resection N/A
Completed NCT04783012 - Patient Removal of Catheters After Urogynecologic Surgery N/A
Recruiting NCT04465578 - Incidence of Short-term Urinary Retention After Fascial Retropubic Sling: Prospective and Randomized Analysis. N/A
Completed NCT03065075 - Effect of Phenazopyridine on Prolapse Surgery Voiding Trials Phase 3
Completed NCT05108506 - Strict Need to Void After Same-day Discharge, Non-urogynecologic, Minimally Invasive Hysterectomy N/A
Enrolling by invitation NCT05887375 - Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery Phase 4
Recruiting NCT03808155 - Prevention of Postoperative Urinary Retention With Treatment of Tamsulosin 5 Days Prior to Lower Limb Arthroplasty Phase 4
Completed NCT04859660 - Pre-operative Tamsulosin and Time to Spontaneous Void After Hysterectomy Phase 2